CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer, Early-Onset
Interventions: DRUG: Neoadjuvant chemotherapy administered before surgical extraction of a tumor|OTHER: Observational
Sponsor: Rutgers, The State University of New Jersey